Home Synthekine

Synthekine

In operation
Series C
Targeted Cytokine Therapeutics Developer
Basic
Enterprise Profile

Basic Information

Synthekine is a developmental-stage biologics company engineering novel specificity, selectivity, and potent cytokine therapies. Guided by their deep expertise in immunology, their targeted protein engineering delivers transformative immunotherapies for the treatment of cancer and autoimmune diseases.
Synthekine
California,United States of America
15~50 people
January 01, 2018
--

Enterprise Profile

Industrial Sector
New Drug Development Biological Product Manufacturing
Technology
Genetic Engineering Targeted Technology Cell Technology
Concept
Disease Treatment Immune System Diseases
Application Scenarios
Targeted drugs Innovative Drugs Biological Products Recombinant Protein